Signs "Most-Favored-Nation" executive order on drug pricing

Trump signed an executive order tying Medicare drug prices to the lowest price paid by other wealthy nations, reviving a controversial policy from his first term. The "Most-Favored-Nation" model aims to drastically cut pharmaceutical costs but faces fierce opposition from the pharmaceutical industry and potential legal challenges. The order was framed as ending the "global freeloading" on U.S. drug innovation.

"Americans will no longer be forced to pay almost three times more for the exact same medicines." — Executive Order text